Article

Comprehensive preclinical evaluation of how cardiac safety profiles of potential COVID-19 drugs are modified by disease associated factors.

2021-02-25

Abstract excerpt

<h4>Background: </h4> and Purpose: Hydroxychloroquine and chloroquine, alone or in combination with azithromycin, have been proposed as therapies for COVID-19. However, there is currently scant and inconsistent data regarding their proarrhythmic potential in these patients. Moreover, their risk profile in the setting of altered physiological states encountered in patients with COVID-19 (i.e. febrile state, electro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a734d774-46c3-59e7-9bff-0674e1d9c5ee
DOI: 10.22541/au.161429217.72966648/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comprehensive preclinical evaluation of how cardiac safety profiles of potential COVID-19 drugs are modified by disease associated factors.DOI 10.22541/au.161429217.72966648/v1Read

Use of hiPSC-derived cardiomyocytes to rule out proarrhythmic effects of drugs: the case of hydroxychloroquine in COVID-19Semantic proximity Read

Hydroxychloroquine and azithromycin: As a double edge sword for COVID-19?Semantic proximity Read

HPC framework for in-silico trials on 3D virtual human cardiac population to assess drug-induced arrhythmic riskSemantic proximity Read

Blinded In Silico Drug Trial Reveals the Minimum Set of Ion Channels for Torsades de Pointes Risk AssessmentSemantic proximity Read

Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugsSemantic proximity Read

Thorough QT/QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration‐QTc RelationshipsSemantic proximity Read

Dangerous and life-threatening drugs - practical lessons from the long QT syndrome.Semantic proximity Read

Prime-edited isogenic hiPSC-derived cardiomyocyte model of short QT syndrome type 3 reveals electrophysiological phenotypes and differential drug responses.Semantic proximity Read

Hydroxychloroquine Attenuates hERG Channel by Promoting the Membrane Channel Degradation: Computational Simulation and Experimental Evidence for QT-Interval Prolongation with Hydroxychloroquine Treatment.Semantic proximity Read

Drug-induced torsades de pointes: the evolving role of pharmacogenetics.Semantic proximity Read

In vitro to in vivo extrapolation from 3D hiPSC-derived cardiac microtissues and physiologically based pharmacokinetic modeling to inform next-generation arrhythmia risk assessmentSemantic proximity Read

Can In Silico Models Predict Drug-Induced Cardiac Risk in Vulnerable Populations?Semantic proximity Read